Clovis Oncology Inc (CLVS.OQ)
* Shares of rival Clovis Oncology also rise (Adds details; analyst comments)
* Clovis Oncology Inc files for mixed shelf of up to $200 million Source text: http://1.usa.gov/1XdI04i Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
* Nineteen patients (9%) discontinued treatment because of an adverse event.
* Clovis oncology announces q1 2016 operating results and corporate update
An independent panel of experts advising the U.S. Food and Drug Administration recommended that Clovis Oncology Inc's lung cancer drug not be approved based on existing trial data.
* Shares fall as much as 18.7 percent (Adds detail, comments from company, analyst)
April 12 An independent panel of experts advising the U.S. Food and Drug Administration did not back the accelerated approval of Clovis Oncology Inc's lung cancer drug.
U.S. Food and Drug Administration staff members on Friday questioned whether Clovis Oncology Inc's lung cancer drug was superior to existing treatments and also raised concerns about its safety profile.
* Shares fall 5 pct in choppy trading (Adds analyst comment; updates shares)
BRIEF-Clovis Oncology VP Daniel Muehl appointed as principal financial officer and principal accounting officer
* Daniel Muehl, co's vice president of finance, appointed as company's principal financial officer and principal accounting officer Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
|Eisai Co., Ltd (4523.T)||¥5,795||+107.00|
|Pfizer Inc. (PFE.N)||$35.57||+0.36|
|AstraZeneca plc (AZN.L)||4,502.50p||+35.50|
|BioMarin Pharmaceutical Inc. (BMRN.OQ)||$81.38||+3.58|
|TESARO Inc (TSRO.OQ)||$81.06||-2.99|
|AbbVie Inc (ABBV.N)||$62.71||+0.80|
|Novartis AG (NOVN.S)||CHF80.45||+0.30|
|Johnson & Johnson (JNJ.N)||$121.29||-0.01|
|Eli Lilly and Co (LLY.N)||$78.95||+0.20|
|GlaxoSmithKline plc (GSK.L)||1,600.00p||-4.50|
Earnings vs. Estimates
Analyst Research Reports
Provider : Thomson Reuters Stock Report
Trading Report for (CLVS). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : ValuEngine, Inc.
Clovis Oncology Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.